Advanced Enzyme Technologies Ltd

Ticker: ADVENZYMES
Decent 68/100

☆ Add to Watchlist

Investing Reference

Price
305.70
Market Cap
3421.60
Debt/Equity
0.0268
ROE %
9.233
PB
2.3297
Promoter %
43.077
Pledge %
0.000
1Y Rev Growth %
1.426
5Y Rev Growth %
8.302
NP Margin %
19.569
NP Margin 5Y Avg %
21.860

Trading Reference

1M Return %
-9.906
6M Return %
5.944
1Y Return %
-36.418
% Away 52W High
69.414
% Away 52W Low
18.534
Daily Volume
175345
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Advanced Enzyme Technologies Ltd is currently trading near a strong support level, with recent volume indicating increased buying interest. If it breaks above the resistance level established at the recent high, there is potential for upward momentum. However, if it fails to hold the support, a decline could occur.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Advanced Enzyme Technologies Ltd is a leading biotechnology company in India, specializing in enzyme manufacturing and application. Catering to diverse industries such as food, pharmaceuticals, and biofuels, the company focuses on innovative solutions that enhance efficiency and sustainability. With a commitment to quality and research, Advanced Enzyme Technologies plays a vital role in promoting eco-friendly practices and improving product performance.

  • Pioneering enzyme solutions for various industries
  • Strong focus on research and development
  • Commitment to sustainability and eco-friendly practices
  • Robust client base across food and pharmaceuticals
  • Expertise in enhancing production efficiency

Investment Thesis

Advanced Enzyme Technologies Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This positions the company well for sustainable growth and offers a compelling investment opportunity for retail investors.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital services, tapping into new revenue streams.
  • Attractive valuation metrics compared to industry peers, presenting a buying opportunity.
  • Solid fundamentals and innovative product offerings support long-term growth.
  • Favorable market trends in the enzyme sector bolster growth prospects.

Opportunity vs Risk

Opportunities
  • Growing demand for enzyme products
  • Expansion into international markets
  • Strong R&D capabilities
  • Strategic partnerships with key players
  • Increasing focus on sustainable solutions
Risks ⚠️
  • Regulatory changes impacting operations
  • Intense competition in the sector
  • Dependence on key customers
  • Fluctuating raw material costs
  • Market volatility affecting stock price

Peer Perspective

Advanced Enzyme Technologies Ltd trades at a slight premium to peers like Biocon and Divi's Laboratories, reflecting its growth potential. A sustained improvement in margins could trigger a rerating, aligning it more closely with industry leaders.

Future Outlook

Advanced Enzyme Technologies Ltd is well-positioned for growth, leveraging its innovative solutions in the enzyme sector. Successful execution of its strategic initiatives and effective cost control will be crucial to maximizing shareholder value.

AI FAQs for Retail Users

  • Q: What does Advanced Enzyme Technologies Ltd do?
    A: The company specializes in manufacturing enzymes for various industries, including food, pharmaceuticals, and biofuels.
  • Q: Is Advanced Enzyme Technologies Ltd a profitable company?
    A: The company has reported profits in recent years, but profitability can vary based on market conditions.
  • Q: What are the risks of investing in this stock?
    A: Risks include market volatility, regulatory changes, and competition in the enzyme industry.
  • Q: How can I buy shares of Advanced Enzyme Technologies Ltd?
    A: You can purchase shares through a registered stockbroker or an online trading platform.
  • Q: What factors influence the stock price of Advanced Enzyme Technologies Ltd?
    A: Stock prices can be influenced by company performance, industry trends, and overall market conditions.
📊 Stock Investment Checklist (100 Points)
Advanced Enzyme Technologies Ltd • Updated: 2025-09-17 01:08:27
  • 10
    Business
    High
    The sector is growing with increasing demand for enzymes in various industries, but competition is intense.
  • 10
    Growth
    High
    Revenue growth has been consistent, but profit margins have fluctuated.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF has shown variability compared to net profit.
  • 8
    Valuation
    High
    P/E and P/B ratios are higher than peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios could be improved.
  • 6
    Governance
    Good
    Promoter holding is strong, but there are concerns about pledging.
  • 5
    Drivers
    Good
    Growth drivers exist, but execution risks are significant.
  • 5
    Technicals
    Good
    Market sentiment is mixed, with low liquidity impacting price action.
Final Score & Verdict
Score 68 / 100 • Decent
Advanced Enzyme Technologies Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 70/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.